<DOC>
	<DOC>NCT01121315</DOC>
	<brief_summary>To describe the type II diabetes population in primary care with special reference to treatment, other diseases and mortality during the last decade. To test the hypothesis that the type or combination of per oral glucose lowering drugs have different effects on the risk of cardiovascular disease and diabetic complications.</brief_summary>
	<brief_title>A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Patients with type II diabetes, according to medical records, diagnosis, prescription or lab assessments Patients followed by physician for less than 6 months after diagnosis of Diabetes type II</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Epidemiological</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Glucose Lowering Drug Treatment in Primary care</keyword>
	<keyword>CVD</keyword>
</DOC>